Cell-Based assays Market Size To Reach USD 28.2 Billion By 2028 Says Reports And Data

Global research report called Cell-Based assays market was recently published by Reports and Data. to provide guidance for the business. The new research study on Cell-Based assays market sheds light on the current scope as well as on the upcoming opportunities in the future. The global cell-based assays market size is expected to reach USD 28.2 Billion by 2028 and register a CAGR of 8.5% over the forecast period, according to the latest report by Reports and Data. Some key factors such as growing funding by public and private sectors and increasing utilization of cell-based assays in drug discovery are driving global market revenue growth.

Cell-based assay is a technique used for analyzing living cells based on various parameters and also aids in measuring cell toxicity, motility, proliferation in diagnostics and drug discovery. High demand for cell-based assays in drug discovery and development is rapidly escalating revenue growth. Moreover, technological developments in cell-based assays, and rising adoption of 3D-based cell assays, and increasing need for developing biologically relevant substitutes for drug discovery are some significant factors boosting market growth.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/3997

Overall high cost of assays due to high maintenance and instrument costs, lack of skilled professionals, and stringent regulations on reagent usage are some key factors expected to hamper growth of the cell-based assays market to some extent throughout the forecast period.

Leading companies in the global cell-based assays market:

are Danaher Corporation (US), Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), PerkinElmer, Inc. (US), Promega Corporation (US), Charles River Laboratories (US), Lonza (Switzerland), BioAgilytix Labs (US), Reaction Biology Corporation (US), and AAT Bioquest (US).

Some key highlights from the report:

Based on product and services, the consumables segment is expected to account for robust revenue contribution between 2021 and 2028 owing to factors such as high demand for consumables in pharmaceutical sector and increasing of R&D activities on drug discovery.
On basis of end-use, the pharmaceutical and biopharmaceutical companies segment dominated other end-user segments in 2020 and is expected to account for significant revenue growth over the forecast period. Increasing competition among well-established healthcare companies and increasing collaborations among these for developing novel and enhanced drugs are some key factors surging revenue growth of this segment.
Asia Pacific market revenue is projected to expand at the fastest CAGR of 11.6% over the forecast period. Increasing number of pharmaceutical companies globally and rising investments in research development in life sciences and drug developmental activities are some key factors supporting market growth in the region.
North America is expected to dominate other regional markets in terms of revenue share during the forecast period due to presence of major manufacturing companies, rapid growth in drug development and research along with substantial funding from government and private organizations, and high implementation of advanced techniques in countries in the region.
In April 2019, PerkinElmer acquired Cisbio Bioassays, which is one of the leading life science companies that manufactures high-quality kits and reagents. This acquisition is expected to widen PerkinElmer’s product range in the market.

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/3997

For this study, Reports and Data has segmented the global cell-based assays market based on product and services, application, end-use, and region:

Based On Product And Service (Revenue, USD Billion, 2018 - 2028)

Consumables
Reagents
Assay Kits
Reporter Gene Assays
Cell Growth Assays
Second Messenger Assays
Cell Death Assays
Other Assay Kits
Cell Lines
Immortalized Cell Lines
Primary Cell Lines
Stem Cell Lines
Microplates
Probes & Labels
Other Consumables
Instruments & Software
Services

Based On Application: (Revenue, USD Billion, 2018 - 2028)

Drug Discovery
Toxicity Studies
Pharmacodynamics Studies
Pharmacokinetic Studies
Basic Research
Other Applications

Based On End Use: (Revenue, USD Billion, 2018 - 2028)

Pharmaceutical & Biopharmaceutical Companies
CROs
Academic & Research Institutes

Based On Region: (Revenue, USD Billion, 2018 - 2028)

North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Rest Of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Rest of MEA

Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/3997

Explore Reports and Data's Prime Analysis of the global Pharma and Healthcare:

Gene Panel Market: https://www.reportsanddata.com/report-detail/gene-panel-market

Cell Viability Assays Market: https://www.reportsanddata.com/report-detail/cell-viability-assays-market

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Our Innovative Blogs @ https://www.reportsanddata.com/blogs

Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.